Evidence map›Paper›PMID 33210462›Full record

ArticleJournal of cellular and molecular medicine2021

MiR155 modulates vascular calcification by regulating Akt-FOXO3a signalling and apoptosis in vascular smooth muscle cells.

Yong Li, Wei Sun, Fatma Saaoud, Yuzhen Wang, Quanyi Wang, Johnie Hodge, Yvonne Hui, Sophia Yin, Susan M Lessner, Xiangqing Kong and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. FOXO3a deregulation in uterine smooth muscle tumors.Clinics (Sao Paulo, Brazil) · 2024
    Article
  13. Article
  14. eLife · 2023
    Article
  15. Review
  16. Ataxin-10 Inhibits TNF-Mediators of inflammation · 2021
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Yong LiDepartment of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, SC, USA.
Wei SunDepartment of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, SC, USA.
Fatma SaaoudDepartment of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, SC, USA.
Yuzhen WangDepartment of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, SC, USA.
Quanyi WangDepartment of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, SC, USA.
Johnie HodgeDepartment of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, SC, USA.
Yvonne HuiDepartment of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, SC, USA.
Sophia YinDepartment of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, SC, USA.
Susan M LessnerDepartment of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, SC, USA.
Xiangqing KongDepartment of Cardiology and Department of Cardiothoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Daping FanDepartment of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, SC, USA.ORCID 0000-0002-4729-761X
University of South Carolina · USJiangsu Province Hospital · CN

Funding

Use of Resveratrol to treat experimental multiple sclerosisP01AT003961 · NCCIH · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI NAGARKATTI, PRAKASH S · 2007 to 2018
$14.2M
Medial Arterial Calcification: Mechanisms and TherapyR01HL145064 · NHLBI · CLEMSON UNIVERSITY · PI VYAVAHARE, NAREN R · 2019 to 2022
$2.3M
Emodin as a chemopreventive agent for breast cancer - admin suppR01CA218578 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI FAN, DAPING, MURPHY, ELIZABETH ANGELA · 2018 to 2022
$1.9M
Sparstolonin B as an anti-atherogenic agentR01HL116626 · NHLBI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI FAN, DAPING · 2013 to 2017
$1.7M
National Natural Science Foundation of China 81100162National Natural Science Foundation of China 81570247NCCIH NIH HHS P01 AT003961NCI NIH HHS R01 CA218578NHLBI NIH HHS R01 HL116626NHLBI NIH HHS R01 HL145064NIH HHS AT003961- 8455NIH HHS HL116626NIH HHS HL145064Six Talent Peaks Project in Jiangsu Province 2015-WSN-29The Priority Academic Program Development of Jiangsu Higher Education Institutions
6 · The paper itself

Abstract

microRNA-155 (miR155) is pro-atherogenic; however, its role in vascular calcification is unknown. In this study, we aim to examine whether miR155 regulates vascular calcification and to understand the underlying mechanism. Quantitative real-time PCR showed that miR155 is highly expressed in human calcific carotid tissue and positively correlated with the expression of osteogenic genes. Wound-healing assay and TUNEL staining showed deletion of miR155 inhibited vascular smooth muscle cell (VSMC) migration and apoptosis. miR155 deficiency attenuated calcification of cultured mouse VSMCs and aortic rings induced by calcification medium, whereas miR155 overexpression promoted VSMC calcification. Compared with wild-type mice, miR155

Indexed as

AnimalsApoptosisCell ProliferationCells, CulturedIn Situ Nick-End LabelingMiceMice, Inbred C57BLMicroRNAsMyocytes, Smooth MusclePhosphatidylinositol 3-KinasesPhosphorylationProto-Oncogene Proteins c-aktReal-Time Polymerase Chain ReactionSignal TransductionMicroRNAsMirn155 microRNA, mousePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktAktapoptosisFOXO3amicroRNA-155vascular calcificationvascular smooth muscle cell

Identifiers

PMID33210462
PMCPMC7810936
OpenAlexW3105997100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.